Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 3.592M
December 31, 2025 2.953M
September 30, 2025 4.490M
June 30, 2025 7.381M
March 31, 2025 9.113M
December 31, 2024 10.73M
September 30, 2024 13.09M
June 30, 2024 14.68M
March 31, 2024 16.42M
December 31, 2023 11.07M
September 30, 2023 12.24M
June 30, 2023 11.62M
March 31, 2023 12.37M
December 31, 2022 14.75M
September 30, 2022 16.49M
June 30, 2022 17.93M
March 31, 2022 19.32M
December 31, 2021 21.03M
September 30, 2021 1.130M
June 30, 2021 1.759M
March 31, 2021 2.501M
December 31, 2020 3.065M
September 30, 2020 0.176M
June 30, 2020 0.2981M
March 31, 2020 0.0048M
Date Value
December 31, 2019 0.0017M
September 30, 2019 0.0981M
June 30, 2019 1.284M
March 31, 2019 0.4963M
December 31, 2018 0.1175M
September 30, 2018 0.1054M
June 30, 2018 0.0035M
March 31, 2018 0.0086M
December 31, 2017 0.4517M
September 30, 2017 0.0007M
June 30, 2017 0.0019M
March 31, 2017 0.0089M
December 31, 2016 0.0318M
September 30, 2016 0.0063M
June 30, 2016 0.5162M
March 31, 2016 0.3531M
December 31, 2015 0.1666M
September 30, 2015 0.0128M
June 30, 2015 0.0064M
March 31, 2015 0.1459M
December 31, 2014 0.0918M
September 30, 2014 0.374M
June 30, 2014 0.0592M
March 31, 2014 0.1104M
December 31, 2013 0.2011M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 115.20M
CareDx, Inc. 373.64M
Natera, Inc. 1.092B
Exagen, Inc. 24.59M
Sera Prognostics, Inc. 46.44M